Optiscan Imaging Limited (AU:OIL) has released an update.
Optiscan Imaging Limited has announced a partnership with the Mayo Clinic to develop an advanced endomicroscopic imaging system for robotic surgery, focusing initially on breast cancer surgery. This collaboration will integrate Optiscan’s digital imaging technology with Mayo Clinic’s expertise in robotic surgery and patient care. As part of this agreement, the Mayo Clinic will also take a financial interest in Optiscan’s technology, aiming to enhance surgical outcomes and reduce repeat procedures.
For further insights into AU:OIL stock, check out TipRanks’ Stock Analysis page.
